Bernard Allan
Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu Takeda Pharmaceutical
Seminars
Thursday 3rd December 2026
A Translational Pharmacology Framework to Drive Antifibrotic Programs
1:30 pm
- Building pathobiology maps from large human transcriptomic, proteomic, and clinical biomarker datasets to identify disease-associated biological modules
- Mapping human pathobiology onto in vitro and in vivo data to identify relevant translational models
- Integrating interventional pathway-specific biomarker data into a self-reinforcing framework for driving programs toward the clinic
